Home > Boards > US Listed > Biotechs >

Opgen (OPGN)

Add OPGN Price Alert      Hide Sticky   Hide Intro
Moderator: mick
Search This Board: 
Last Post: 3/5/2021 3:33:29 PM - Followers: 68 - Board type: Free - Posts Today: 0

Vexing problems oftimes lead to creative solutions. OpGen's robust ingenuity is a case in point.

Problem: "Antibiotic resistance is a global threat. There is no system in place to track antibiotic resistance globally. Without urgent action, many modern medicines could become obsolete, turning even common infections into deadly threats." -U.S. Center for Disease Control

Enter OpGen, Inc.   Press Releases

OpGen, Inc. (Gaithersburg, MD, USA) (Nasdaq OPGN) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to guide clinicians with rapid and actionable information about life-threatening infections to improve patient outcomes and decrease the spread of infections caused by multidrug-resistant microorganisms (MDRO). Subsidiaries include Curetis GmbH and
Ares Genetics GmbH*. 
Partners include Sandoz, QIAGEN, Merck, HIPS, Curetis, BGI, Max Perutz Labs Vienna, MGI. Learn more

OpGen’s product portfolio includes Unyvero, Acuitas AMR Gene Panel, PNA FISH, Quick Fish, Acuitas® Lighthouse, and the ARES Technology Platform. The Ares Technology Platform includes ARESdb (db=database) that uses NGS (next generation sequencing) technology and AI-powered bioinformatics solutions to predict antibiotic response (resistance). Artificial intelligence based DNA testing revolutionizes infectious disease diagnostics and therapeutics.* Patient outcomes improved; costs reduced. Learn more

"Time is of the essence in cases of severe infections, not infrequently a question of life or death, and knowing what not to prescribe is as important as knowing what to prescribe."
 OpGen Corporate Overview 06-Oct-2020  yes (Recommended viewing)

*02Oct2020 OpGen's wholly owned Ares Genetics GmbH* (Vienna) won the Austria State Prize for innovation with their Project "ARESupa- Molecular Antibiotic Resistance Diagnostics using Artificial Intelligence - With a (Ares Genetics) universal pathogen test, antibiotic resistance from germs can be predicted quickly and accurately." yes

OpGen subsidiary Ares Genetics, which combines Next Generation Sequencing (NGS) with ARESdb, is the world‘s most comprehensive database on the genetics of antibiotic resistance. ARESdb is also the world’s largest database of genetic antibiotic resistance markers and predictive AMR panels. ARESdb contains thousands of whole genome sequenced clinical isolates collected from more than 200 centers globally. ARESdb combines broad resistance profiles with high-quality genetic information and enables pathogen identification with up to >99% accuracy and antibiotic resistance detection with ~98% accuracy. ARESdb covers 30 years of emerging antibiotic resistance to accurately detect AMR and combines deep whole-genome sequencing data with antibiotic resistance profiles continuously expanded. Partners include Sandoz, QIAGEN, Merck, HIPS, Curetis, BGI, Max Perutz Labs Vienna, MGI.

                                                   Fast & Simple Syndromic Testing for Severe Infections -- Improving Patient Outcomes yes
                                                           Detects pathogens rapidly, including associated antibiotic resistance genes yes
                                                  Antibiotic resistant microorganisms are a global health threat (Per CDC, WHO, US GAO)

                                                                 Our UNYVERO A50 IS FDA APPROVED yes UNYVERO FLYER (Recommended viewing)  

With the Unyvero A50 Solution, OPGen's wholly owned subsidiary Curetis has developed a molecular diagnostics system for reliable and extremely rapid diagnosis of severe infectious diseases in under 5 hours versus up to 96 hours using current methods. The system uses powerful multiplex PCR technology and syndromic testing to detect a wide variety of microorganisms, antibiotic resistance markers, or toxins.



Unyvero A50 Applications for Major Infectious Disease


    HPN- Hospitalized Pneumonia                                                                
HPN Solution 

     BCU — Blood Culture  
   Analyzes the DNA of 103 pathogens & resistance genes from a
   positive blood culture for fast diagnostics of blood stream infections.

    BCU Solution 

     IAI — Intra-Abdominal Infection
    IAI Solution 

     UTI — Urinary Tract Infection

     UTI Solution 

      ITI — Implant & Tissue Infection       
    ITI Solution 


Unyvero A50 System
Unyvero A50 Cartridge
Unyvero A30 RQ in development

*OpGen Partner Curetis BGI COVID-19 Rapid Test Kits approved by US FDA  March 29, 2020
"The kits are being used in 70 countries and regions including Japan, Brunei, Thailand, The United Arab Emirates, Egypt and Peru."
*OpGen Expands Partnership with New York State Department of Health and IDC to Detect Antimicrobial-Resistant Infections  June 03, 2020
*OpGen Releases Preliminary Data Demonstrating its Unyvero HPN Panel for Pneumonia Identifies Life-Threatening Bacterial Co-Infections in COVID-19  Patients in Just Five Hours  June 09, 2020
*Menarini Silicon Biosystems Partners with OpGen to Broaden Distribution of CELLSEARCH Platform in North America July 13, 2020
*OpGen Co-Markets COVID-19 Antibody Test Kit  August 09, 2020
*OpGen Announces CE-IVD Marking and Commercial Launch in Europe of its Own Developed Molecular Diagnostic SARS-CoV-2 Kit with PULB for Detection of the Virus Causing COVID-19  August 20, 2020
*Collaborative Research by OpGen Group Company Ares Genetics and Johns Hopkins Researchers Demonstrates Potential of Next-Generation Sequencing for Investigation of Genetic Antimicrobial Resistance Mechanisms and Molecular Susceptibility Testing  September 16, 2020
*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
OPGN News: Statement of Changes in Beneficial Ownership (4) 03/05/2021 04:34:19 PM
OPGN News: Statement of Changes in Beneficial Ownership (4) 03/05/2021 04:30:33 PM
OPGN News: OpGen shares gain 17% on Chinese approval of Curetis Unyvero System 03/01/2021 07:42:08 AM
OPGN News: OpGen Wins Chinese NMPA Approval for the Curetis Unyvero System 03/01/2021 07:30:00 AM
OPGN News: Small Company Offering and Sale of Securities Without Registration (d) 02/24/2021 11:29:08 AM
#2322  Sticky Note $OPGN # 2 OpGen Co-Markets COVID-19 Antibody Test Kit mick 08/09/20 06:29:05 PM
#2428   YES OpGen Inc (OPGN) mick 03/05/21 03:33:29 PM
#2427   Good thing I catch the bottom today. Have powerbattles 03/05/21 02:47:08 PM
#2426   i agree OpGen Inc (OPGN) mick 03/04/21 04:00:40 PM
#2425   Way oversold here. Looking to reloaded where is powerbattles 03/04/21 11:26:49 AM
#2424   OpGen Inc (OPGN) mick 02/21/21 12:07:29 PM
#2423   OpGen Inc (OPGN) mick 02/14/21 08:59:13 AM
#2422   Why is antibiotic resistance such a big deal? chillswills37 02/09/21 09:54:30 AM
#2421   OPGN High of the day 4.37 great day powerbattles 02/09/21 12:36:54 AM
#2420   * * $OPGN Video Chart 02-08-2021 * * ClayTrader 02/08/21 04:38:28 PM
#2419   mega crazy knrorrel 02/08/21 03:56:40 PM
#2418   OCGN 14.34 WOOOOOOOOOHOOOOOOOOOOOOO powerbattles 02/08/21 02:20:11 PM
#2417   OCGN KABOOOOOOOOOOOOM WEEEEEEEEEEEEEEEE powerbattles 02/08/21 02:19:23 PM
#2416   why is it going so much up? dose NORMAD79 02/08/21 01:24:06 PM
#2415   $3.90 so far... nice wesley_ 02/08/21 01:17:41 PM
#2414   jmho this is a 20 plus stock..again jmho pivotpoint1 02/05/21 02:27:48 AM
#2413   Yes, I am accumulating the stock for upcoming merge! powerbattles 02/04/21 03:59:20 AM
#2412   Are you really collecting at $OPGN? I can't knrorrel 02/04/21 02:45:32 AM
#2411   Slow moving in the right direction: powerbattles 02/03/21 09:09:05 PM
#2410   good idea $OPGN mick 02/02/21 12:23:53 PM
#2409   I started accumulating since yesterday. powerbattles 02/02/21 11:44:14 AM
#2408   OpGen Inc (OPGN) mick 02/02/21 11:40:15 AM
#2407   OpGen filed and furnished to its stockholders a powerbattles 02/02/21 10:49:55 AM
#2406   Merger? Jiminy Cricket 02/02/21 10:45:41 AM
#2405   ah merger ????? 'Opgen (OPGN)' mick 02/01/21 06:13:55 PM
#2404   OPGN $2.18 merger closing March 10th? powerbattles 02/01/21 01:28:26 PM
#2403   https://otcbb.swingtradebot.com/equities/OPGN N.Y. , NASDAQ mick 01/31/21 08:32:53 PM
#2402   Why?..OPGN is up 10 pct. why are you bigfred1 01/21/21 01:18:42 PM
#2401   Selling OPGN !! and buying POT STOCKS!! borbash 01/21/21 10:16:54 AM
#2400   $OPGN Chair Wm. Rhodes adds another notch to chillswills37 01/07/21 02:54:53 PM
#2399   thank you, i still like $OPGN OpGen Inc (OPGN) mick 01/06/21 05:04:14 PM
#2398   Get Ready Buddy..$OPGN is on fire!!! $2.44 pivotpoint1 01/05/21 07:07:11 PM
#2397   USPTO URL OpGen patent 10,876,162 Key in chillswills37 01/04/21 05:07:02 PM
#2396   AMR: "A threat greater than 'COVID': Why we chillswills37 01/04/21 03:59:23 PM
#2395   12/29/2020 USPTO grants OPGEN key patent. chillswills37 01/04/21 01:20:40 PM
#2394   https://pennystocks.news/otc/?symbol=OPGN mick 01/03/21 01:58:52 PM
#2393   YES HAPPY NEW YEAR TO YOU & FAMILY mick 12/30/20 04:32:53 PM
#2392   OpGen Inc (OPGN) mick 12/30/20 04:31:38 PM
#2391   $OPGN COULD DO WELL WIT VARIABLE COVID VIRUS NOW mick 12/30/20 04:31:25 PM
#2390   She's running.. Happy New Year $$$$$$ pivotpoint1 12/30/20 03:46:09 PM
#2389   Lots of volume...........hmmmm Jiminy Cricket 12/29/20 02:11:15 PM
#2388   Merry Christmas ! Happy New Year! and New Position!...Cheers!!$OPGN pivotpoint1 12/24/20 10:51:56 PM
#2387   https://pennystocks.news/otc/?symbol=OPGN mick 12/21/20 05:34:36 PM
#2386   OpGen Inc (OPGN) mick 12/07/20 11:25:45 AM
#2385   FDA ANYTIME NOW!!! IMO Jiminy Cricket 11/13/20 05:09:21 PM
#2384   OPGN news out today: https://www.marketwatch.com/press-release/opgen-announces- JAH son 10/28/20 02:49:30 PM
#2383   OPGN: Veterinary applications to be developed on Unyvero chillswills37 10/28/20 01:49:07 PM
#2382   OPGN diversifies via $130B market for animal healthcare. chillswills37 10/28/20 01:16:01 PM
#2381   Barchart T/A 100% BUY OPGN despite downturn ($2.35). chillswills37 10/26/20 05:10:40 PM
#2380   Current Report Filing (8-k) Edgar (US Regulatory) - mick 10/25/20 06:09:57 PM
#2379   OpGen Inc (OPGN) mick 10/25/20 06:09:39 PM
Consent Preferences